209 hedge funds and large institutions have $1.37B invested in Genmab in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 81 increasing their positions, 67 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

8% less funds holding

Funds holding: 226209 (-17)

20% less capital invested

Capital invested by funds: $1.72B → $1.37B (-$349M)

33% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 48

Holders
209
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.04M
Puts
$7.01M
Net Calls
Net Calls Change

Top Buyers

1 +$50.5M
2 +$43.7M
3 +$35.4M
4
BlackRock
BlackRock
New York
+$19.6M
5
Capital International Investors
Capital International Investors
California
+$11.6M

Top Sellers

1 -$58.1M
2 -$37.4M
3 -$29.3M
4
Artisan Partners
Artisan Partners
Wisconsin
-$20.5M
5
FAM
Fred Alger Management
New York
-$19.1M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$294K
127
$282K
128
$272K
129
$260K
130
$249K
131
$248K
132
$237K
133
$235K
134
$232K
135
$225K
136
$224K
137
$218K
138
$202K
139
$176K
140
$168K
141
$164K
142
$150K
143
$147K
144
$142K
145
$120K
146
$100K
147
$98K
148
$96K
149
$81K
150
$76K